Bank of New York Mellon Corp Buys 7,747 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Bank of New York Mellon Corp boosted its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 2.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 272,632 shares of the company’s stock after acquiring an additional 7,747 shares during the period. Bank of New York Mellon Corp owned 0.67% of Phibro Animal Health worth $5,725,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Quantbot Technologies LP purchased a new position in Phibro Animal Health during the third quarter valued at $70,000. New York State Teachers Retirement System grew its stake in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares during the period. Zacks Investment Management bought a new stake in shares of Phibro Animal Health during the 3rd quarter valued at about $274,000. SG Americas Securities LLC grew its stake in shares of Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after purchasing an additional 906 shares during the period. Finally, Ieq Capital LLC bought a new position in shares of Phibro Animal Health during the 4th quarter valued at approximately $302,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Performance

PAHC stock opened at $21.25 on Monday. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The business’s fifty day simple moving average is $22.57 and its two-hundred day simple moving average is $22.59. Phibro Animal Health Co. has a twelve month low of $12.05 and a twelve month high of $26.55. The firm has a market cap of $860.69 million, a price-to-earnings ratio of 44.27, a PEG ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is currently 100.00%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday. Barclays upped their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Finally, Morgan Stanley increased their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $21.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.